Boehringer Ingelheim Animal Health

[On Demand]
Boehringer Ingelheim Animal Health is a global leader in the animal health industry and part of the family-owned Boehringer Ingelheim company founded in 1885.

Our innovation approach builds on our track record of developing game-changing therapeutics, parasiticides and vaccines that have significantly contributed to improving animal health and well-being. We concentrate our research efforts in cardiometabolic diseases, CNS diseases, immunology & inflammation, oncology, infectious diseases, pain, parasitology and oral health. We also go beyond medicine to better predict, detect and prevent animal diseases before they arise.

We invest in both external innovation and our own R&D and are actively growing our network of innovation partners. We believe that the power of partnership and diversity of thought enable us to realize even more innovation and that by working together we can achieve more to accelerate the delivery of the next generation of breakthroughs in animal health.
Company Type:
Privately Funded Company
Company HQ State:
Not Provided
Company HQ Country:
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Multiple Products in Pipeline
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Head of Strategic Partnering
Boehringer Ingelheim Animal Health